GlaxoSmithKline plc
Malaria vaccine fails to work after four years: study
Mar 20, 2013 17:21 EDT
A new vaccine that has raised hopes of becoming a potent new tool in the battle against malaria seems to stop working in children after four years, according to research published Wednesday.
British business backs PM's foreign aid pledge
Mar 11, 2013 06:11 EDT
Chief executives of some of Britain's biggest companies -- including BP, Vodafone and GlaxoSmithKline -- on Monday joined the boss of English football's Premier League in stressing the need for Britain to maintain its overseas aid budget.
Drugmaker GSK reveals lower profits, restructuring
Feb 06, 2013 13:31 EST
British drugs firm GlaxoSmithKline on Wednesday unveiled a 13-percent drop in annual net profits and outlined a plan for more restructuring in Europe to deliver greater savings and offset weaker sales across the region.
GlaxoSmithKline plans revamp as profits drop
Feb 06, 2013 07:59 EST
British drugmaker GlaxoSmithKline on Wednesday announced a 13-percent drop in annual profits and said it would further restructure its European operations to deliver greater savings amid weaker sales across the region.
London shares tumble after Barclays resignations
Feb 04, 2013 12:14 EST
.London shares tumbled on Monday as the resignation of two Barclays directors added to gloom about scandals in the UK banking sector
FTSE ends higher on US, manufacturing data
Feb 01, 2013 13:11 EST
London shares closed higher on Friday on reassuring US jobs data and a slight expansion in UK manufacturing in January.
Didier Jambart Claims Drug Requip Turned Him Into A Gay Sex Addict
Dec 04, 2012 19:00 EST
Glaxo has been ordered to pay $250,000 in damages to a man who claims Requip turned him into a gay sex addict. A French court has ordered British pharmaceutical giant GlaxoSmithKline to pay $250,000 in damages to Didier Jambart, who claims the manufacturer's Requip, also known as Ropinirole, turned him into a gay sex and gambling addict. Jambart, a 52-year-old married father of two, began taking the drug in 2003 to treat his Parkinson's symptoms. While taking the drug, Jambart claims he developed wild urges for online gambling and anonymous sexual encounters with men. ?It's a great day,? Jambart is quoted as saying by the AFP. ?It's been a seven-year battle with our limited means for recognition of the fact that GSK lied to us and shattered our lives.? Jambart said he became suicidal after he gambled this family's life savings, and tried to kill himself eight times. He also began cross-dressing. He said he was raped during an illicit encounter he had arranged. A 2010 study published in
London shares close flat amid 'fiscal cliff' fears
Nov 28, 2012 12:35 EST
London shares closed flat on Wednesday amid renewed concern about the looming "fiscal cliff" of automatic tax rises and spending cuts which threatens to send the United States back into recession, dealers said.
Glaxo loses 'gay sex addict' court appeal
Nov 28, 2012 12:03 EST
A French appeals court Wednesday upheld a ruling ordering British pharmaceutical giant GlaxoSmithKline to pay 197,000 euros to a man who claimed that its drug to treat Parkinson's turned him into a gay sex and gambling addict.
French court upholds GSK Parkinson's drug ruling
Nov 28, 2012 10:16 EST
A French appeals court Wednesday upheld a ruling ordering pharmaceutical giant GlaxoSmithKline to pay 197,000 euros to a man who claimed that its drug to treat Parkinson's turned him into a gay sex and gambling addict.
GSK unveils expansion plans in India, Nigeria
Nov 26, 2012 08:16 EST
British drugmaker GlaxoSmithKline said it intends to increase its holdings in its Indian and Nigerian divisions, as part of a long-term strategy to expand into emerging markets, in a statement on Monday.
GSK bids $940 million to hike stake in Indian unit
Nov 26, 2012 06:06 EST
Britain's GlaxoSmithKline announced on Monday a $940-million bid to sharply increase its stake in its Indian consumer products unit, sending shares of the local company to a record high.
World anti-doping agency says 'lacks funding'
Nov 12, 2012 12:02 EST
The World Anti-Doping Agency (WADA) on Monday called for wider efforts to tackle the use of banned substances in sport, warning that lack of funding was hampering its fight against increasingly sophisticated cheating.
Mixed results for malaria trial vaccine
Nov 09, 2012 10:59 EST
New tests with a candidate malaria vaccine have shown it to be less effective in weeks-old infants than older babies, a "frustrating" result in the fight against the killer disease.
GlaxoSmithKline says Q3 net profits drop 18.5%
Oct 31, 2012 10:34 EDT
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profits fell 18.5 percent from a year earlier to £1.12 billion ($1.80 billion, 1.39 billion euros), hit by weak conditions in Europe.
London shares close higher
Oct 30, 2012 13:00 EDT
London shares closed higher on Tuesday, lifted by strong profits at oil giant BP as investors shrugged off the continued closure of Wall Street, dealers said.
London shares end lower as Wall Street stays shut
Oct 29, 2012 12:55 EDT
London shares closed lower amid renewed worries about Greek debt and in the absence of US investors with Wall Street closed because of Hurricane Sandy, dealers said.
FTSE rebounds on US jobs claims fall
Oct 11, 2012 12:40 EDT
London shares rebounded to end higher on Thursday, shrugging off Standard & Poor's slashing Spain's credit rating, and gaining added steam from a big drop in US jobs claims.
Swine flu vaccine linked to child narcolepsy: EU watchdog
Sep 21, 2012 15:33 EDT
A swine flu vaccine used in 2009-10 is linked to a higher risk of the sleeping disorder narcolepsy in children and teens in Sweden and Finland, the European Centre for Disease Prevention and Control said Friday.
Poor retail sales knock back US stocks
Jul 16, 2012 16:59 EDT
US stocks closed lower Monday after an unexpected fall in retail sales in June, the third consecutive drop that fueled concerns about the strength of consumer spending, a key driver of the economy.
Facts from the Wikipedia page:
| Type | Public (LSE: GSK NYSE: GSK) |
|---|---|
| Founded | 2000, by merger of Glaxo Wellcome and SmithKline Beecham |
| Headquarters | London, United Kingdom |
| Key people | Sir Chris Gent, Chairman Andrew Witty, Chief Executive Julian Heslop, Chief Financial Officer Dr. Moncef Slaoui, Chairman of Research and Development |
| Industry | Pharmaceutical |
| Products | Pharmaceuticals |
| Revenue | £24.352 billion (2008) |
| Operating income | £8.259 billion (2008) |
| Net income | £4.712 billion (2008) |
| Employees | 103,000 (2008)[1] |
| Website | www.gsk.com |